Research Informatics & In-silico Drug Discovery


Drug discovery design efforts

Laxai in-silico team excels in drug discovery design efforts in collaboration with medicinal chemistry, structural biology, chemical biology and DMPK teams, by conducting molecular modelling studies – pharmacophore and QSAR modelling, protein structure-based drug design, ligand-based drug design, fragment-based drug design, homology modelling, docking & scoring, chemo-informatics analysis and de novo designs. The team extensively utilizes in-house expertise in software development, chemo-curation for driving molecular designs.